BIA Networking Lunch - Glasgow
Apologies but this event is now cancelled due to weather conditions.
Join us at BioCity Scotland for the first BIA regional networking event of the year. Come along to hear showcase presentations from local Scottish Biotech companies, MedAnnex and Novabiotics. This is an ideal opportunity to network with colleagues, meet new contacts and hear from local members. Free to attend.
Topics to be announced shortly
Meet our speakers
Dr Ian W Campbell
Dr Ian Campbell is an experienced executive in life sciences and the diagnostics sector. In October 2016 Ian took up the post of Director for Health and Life Sciences at Innovate UK. Prior to that, he most recently served as Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay tests for cancers of the urinogenitary tract.
Previously he served as Chief Executive of Imperial College spin-out company Molecular Vision, developing a disposable, quantitative point-of-care diagnostic platform, before being acquired by Abingdon Health in 2012. Ian has also served as Commercial Director with Bespak Europe. Ian has a strong scientific background, gaining his PhD at the University of Glasgow.
Dr Tina Flatau
Tina is the Managing Director of MedAnnex and sits on MedAnnex’s Executive Team and Scientific Advisory Board.
Tina has a PhD in pharmaceutics and has worked in pharmaceutical and biotechnology R&D for over 25 years. A Principal in PwC’s Pharmaceutical Industry Group, since 2002 she has worked in a management and advisory capacity in the biopharmaceutical sector; her clients have included Wyeth Biopharma/Pfizer Biotechnology, Novartis Biotechnology Centre, Celltech/UCB, Sanofi Aventis, Roche and CAT/MedImmune/AZ. From 2009 to 2014 Tina worked with Prosensa Therapeutics, a rare disease company in RNA modulation technology, where she led the business side of the company’s float on NASDAQ in 2013. As Vice President responsible for the development portfolio and alliances, Tina oversaw the development pipeline and out-licensing, with strategic partners in academia, industry and patient organisations, and the progress of Prosensa’s lead programme towards regulatory market submissions. Tina has been working with Edinburgh-based MedAnnex Ltd since 2015.
Dr Deborah O'Neil
A biotechnologist with two decades of experience in the field of anti-infectives research & drug development, Deborah studied immunology at University College London and then worked in internationally acclaimed laboratories in San Diego and Ghent before moving to Aberdeen. It was here where, in order to fully develop the commercial potential of her platform of novel antibacterial and antifungal therapies, she founded NovaBiotics in 2004. Deborah has since grown the business - as its Chief Executive & Scientific Officer - into a leading global biotechnology company with a portfolio of clinical-stage and preclinical anti-infective drug candidates for medically unmet infectious diseases. Deborah is editor of the European Biopharmaceutical Review and International Pharmaceutical Technology, a member of the Scottish Life Science Industry Leadership Group and sits on the Advisory Board of the Scottish Life Sciences Association. Deborah is also a member of the newly formed Life Sciences board of Opportunity North East and an elected Board Member of Aberdeen & Grampian Chamber of Commerce as well as being a proud Trustee of Crohn’s in Childhood Research Association.
Dr Martin Turner
Martin joined the BIA in April 2016 as Policy and Projects Manager and was promoted to Head of Policy and Public Affairs in January 2019. He is responsible for the BIA's policy outputs and public affairs activities. He also leads on innovation and industrial strategy policy and provides the secretariat for the BIA’s Finance and Tax Advisory Committee and the Intellectual Property Advisory Committee.
Martin has eight years’ experience in policy and public affairs and has worked at the Royal Society, the Campaign for Science and Engineering, and the Association of Medical Research Charities. Before embarking on a career in policy, Martin completed a PhD in molecular biology at the University of Sheffield, where he also co-founded and was director of an award-winning science communication charity called Science Brainwaves. He has a BSc in molecular biology from the University of Manchester.
12:00 - 13:00 Registration, networking and lunch
13:00 - Welcome and BIA update, Steve Bates, BIA
13.10 - BioCity welcome and update, Toby Reid, BioCity Group
13.20 - Professor Graham Ball, CompanDx
13.40 - Professor Steven Chalton, Excellerate Bioscience
14:00 - 14:30 Further networking